European Wax Center (EWCZ) IPO Opens 12% Higher

Today's IPO for European Wax Center (NASDAQ: EWCZ) opened for trading at $19 after pricing 10,600,000 shares of its Class A common stock, including 1,684,794 shares of Class A common stock to be sold by certain existing stockholders, at a price to the public of $17.00 per share.

Morgan Stanley, BofA Securities, and Jefferies are serving as joint lead book-running managers and as representatives of the underwriters for the offering. Citigroup, Guggenheim Securities, Truist Securities and Baird are serving as bookrunners for the offering. Telsey Advisory Group, Academy Securities, Penserra Securities LLC and R. Seelaus & Co., LLC are serving as co-managers for the offering.

European Wax Center, Inc. is a leading personal care franchise brand founded in 2004. They offer expert wax services from certified Wax Specialists, ensuring that every guest who walks through the door leaves feeling confident—in European Wax Center and themselves. European Wax Center provides guests with a first class, professional waxing experience by the most highly trained estheticians in the industry, within the privacy of clean, individual waxing suites. They’re so certain everyone will love the European Wax Center experience, European Wax Center offers a free complimentary wax to each new guest. European Wax Center continues to revolutionize the waxing category with their innovative, signature Comfort Wax™. This proprietary blend is formulated with the highest quality ingredients to leave skin feeling smooth and make waxing an efficient and relatively painless experience. To help enhance and extend waxing services after leaving the center, European Wax Center offers a full collection of proprietary products in the skincare, body, and brow categories. European Wax Center is a leading wax specialty personal care brand in the United States, and its network now includes 808 centers nationwide.

You May Also Be Interested In

• ITG prices IPO at $16 per share on Nasdaq
• Idaho Copper files to uplist to NYSE American from OTC Pink market
• Neurogene launches public offering of common stock